Pulmonary hypertension is a common consequence of interstitial lung disease (PH-ILD), with the highest rate seen among ...
Background Patients with transthyretin amyloid cardiomyopathy (ATTR-CM) often experience worsening cardiac disease (WCD) ...
According to a new market research report titled, 'Cardiac Biomarkers Market Size, Share, Forecast, & Trends Analysis by Type ...
A risk-assessment tool incorporating NT-proBNP and high-sensitivity troponin performs better than clinical scores for ...
According to a new market research report titled, 'Cardiac Biomarkers Market Size, Share, Forecast, & Trends Analysis by Type (Troponin, CK-MB ...
Inter-atrial shunt device therapy has shown mixed results in clinical trials, with clinical 'non-responders' typically showing features of more advanced heart failure. We aimed to analyse the ...
Iguratimod (IGU) is a disease-modifying anti-rheumatic drug (DMARD) that treats rheumatoid arthritis (RA) and other ...
Historical data show the prevalence of pulmonary arterial hypertension (PAH) in adult patients with congenital heart disease ...
Cytokinetics (CYTK) announced five presentations related to aficamten, an investigational cardiac myosin inhibitor, and hypertrophic ...
Good afternoon, ladies and gentlemen, and welcome to the Zomedica fourth quarter 2024 financial results conference call. (Operator Instructions) This call is being recorded on Thursday, March 13, 2025 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback